副专业医生对C型肝炎治疗障碍和促进因素的看法:一种定性研究
Erin Bredenberg1, Catherine Callister2, Ashley Dafoe3
1Division of Hospital Medicine, University of Colorado School of Medicine, 4th Floor, Leprino Building 12401 E 17th Ave, Aurora, CO, 80045, USA. Erin.Bredenberg@CUAnschutz.edu.
Harm reduction journal
|July 25, 2024
概括
医生的见解表明,将型肝炎病毒 (HCV) 治疗纳入初级保健和物质使用障碍设施,使用远程医疗和多学科团队,可以克服治疗患者最后一英里的障碍.
科学领域:
- 肝病学 肝病学是一种肝病学.
- 传染性疾病 传染性疾病
- 成 药物 药物 药物 药物
背景情况:
- 型肝炎病毒 (HCV) 感染对全球健康造成重大负担,发达国家的发病率越来越高,特别是在注射毒品的人群中.
- 在有物质使用障碍 (SUD) 的患者中,HCV治疗率持续低于最佳水平.
研究的目的:
- 探索子专科医生关于HCV治疗障碍和促进者的观点.
- 了解医生对同时出现SUD的患者治疗HCV的观点.
主要方法:
- 半结构面试与美国12所机构的20名亚专科医生进行.
- 使用快速矩阵技术的混合演和归纳方法进行定性内容分析.
主要成果:
- 确定的主要主题包括对患者复杂性的看法,护理的系统性障碍以及多学科团队的重要性.
- 副主题强调了患者层面的因素,提供者层面的因素和保险要求作为重要影响因素.
结论:
- 分散的护理模式,远程医疗和与初级保健,SUD设施和减少伤害地点的整合对于接触未经治疗的HCV患者至关重要.
- 多学科团队,包括药剂师和同行导航员,提高治疗的成功.
- 消除繁的监管要求对于扩大获得HCV治疗的机会至关重要.
相关概念视频
Hepatic Drug Clearance: Role of Transporters
51
In the liver and bile canaliculi, influx and efflux transporters modification can influence intrinsic clearance. Transporters play a significant role in moving drugs within liver cells. Elaborate models, such as the Biopharmaceutical Classification System (BCS), are essential to relate transporters to drug disposition. This system categorizes drugs into four classes based on solubility and permeability, providing insights into elimination routes and the effects of transporters following oral...
51
Esophageal Varices-II: Clinical Features and Management
57
Esophageal varices often manifest as gastrointestinal bleeding episodes, presenting symptoms like hematemesis (vomiting of blood), hematochezia (passing fresh blood via the rectum), and melena (black, tarry stools). Other signs can include weight loss, anorexia, abdominal discomfort, jaundice, pruritus, altered mental status, and muscle cramps.
In the initial assessment, a thorough review of the patient's medical history is vital to identify risk factors such as liver disease, alcohol...
In the initial assessment, a thorough review of the patient's medical history is vital to identify risk factors such as liver disease, alcohol...
57
Physiological Pharmacokinetic Models: Incorporating Hepatic Transporter-Mediated Clearance
36
Drug transporters are critical in drug absorption, distribution, and excretion processes. They should be included in physiological-based pharmacokinetic (PBPK) models, which help predict human drug disposition. However, predicting this is challenging during drug development, especially when liver transport is involved. However, with a realistic representation of body transport processes, an accurate model may be possible.
A recent model describes pravastatin's hepatobiliary excretion,...
A recent model describes pravastatin's hepatobiliary excretion,...
36
Barriers to Effective Communication II
3.6K
The barriers to effective communication also include cultural barriers, semantic barriers, gender barriers, and time constraints.
Cultural barriers:
Differences in values, beliefs, religion, knowledge, and tradition can significantly impact communication. Awareness of nonverbal cues is critical, especially when conversing with a patient from a different culture. What appears appropriate in one culture may be inappropriate in another.
Semantic barriers:
As a result of their tendency to use...
Cultural barriers:
Differences in values, beliefs, religion, knowledge, and tradition can significantly impact communication. Awareness of nonverbal cues is critical, especially when conversing with a patient from a different culture. What appears appropriate in one culture may be inappropriate in another.
Semantic barriers:
As a result of their tendency to use...
3.6K
Chronic Pancreatitis II: Collaborative Care
79
The management of chronic pancreatitis is multifaceted, involving a comprehensive approach that includes thorough assessment, diagnostic testing, and a variety of management strategies.
Assessment:
Assessment:
79
Ultrasound II: Endoscopic Ultrasound and FibroScan
89
Endoscopic Ultrasound (EUS) and FibroScan are valuable diagnostic tools in gastroenterology and hepatology, each with specific applications and techniques.
Endoscopic Ultrasound (EUS):
Endoscopic Ultrasound (EUS):
89


